|
STEMCELL Technologies Inc
cd4 + t-cell isolation kit ![]() Cd4 + T Cell Isolation Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/stem+cell+easysep+kit+for+cd4+++t+cells/pmc08103102-341-16-23?v=STEMCELL+Technologies+Inc Average 90 stars, based on 1 article reviews
cd4 + t-cell isolation kit - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
STEMCELL Technologies Inc
mouse cd4+ t cell enrichment kit ![]() Mouse Cd4+ T Cell Enrichment Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/stem+cell+easysep+kit+for+cd4+++t+cells/pmc02711963-109-11-18?v=STEMCELL+Technologies+Inc Average 90 stars, based on 1 article reviews
mouse cd4+ t cell enrichment kit - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
STEMCELL Technologies Inc
easysep human cd4 t cell isolation kit ![]() Easysep Human Cd4 T Cell Isolation Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/stem+cell+easysep+kit+for+cd4+++t+cells/pm34343484-114-153-160?v=STEMCELL+Technologies+Inc Average 90 stars, based on 1 article reviews
easysep human cd4 t cell isolation kit - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
STEMCELL Technologies Inc
human cd4+ t cell magnetic beads ![]() Human Cd4+ T Cell Magnetic Beads, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/stem+cell+easysep+kit+for+cd4+++t+cells/pm27905985-60-12-19?v=STEMCELL+Technologies+Inc Average 90 stars, based on 1 article reviews
human cd4+ t cell magnetic beads - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
STEMCELL Technologies Inc
naïve cd4 t cell iso kit ii ![]() Naïve Cd4 T Cell Iso Kit Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/stem+cell+easysep+kit+for+cd4+++t+cells/10__7554_slash_elife__78738-352-9-18?v=STEMCELL+Technologies+Inc Average 90 stars, based on 1 article reviews
naïve cd4 t cell iso kit ii - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
STEMCELL Technologies Inc
easysep human naïve cd4+ t cell isolation beads (stem cell technology) ![]() Easysep Human Naïve Cd4+ T Cell Isolation Beads (Stem Cell Technology), supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/stem+cell+easysep+kit+for+cd4+++t+cells/pmc05606324-335-29-37?v=STEMCELL+Technologies+Inc Average 90 stars, based on 1 article reviews
easysep human naïve cd4+ t cell isolation beads (stem cell technology) - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
STEMCELL Technologies Inc
mouse cd4 + t cell isolation kit ![]() Mouse Cd4 + T Cell Isolation Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/stem+cell+easysep+kit+for+cd4+++t+cells/pmc06857089-81-12-21?v=STEMCELL+Technologies+Inc Average 90 stars, based on 1 article reviews
mouse cd4 + t cell isolation kit - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
STEMCELL Technologies Inc
magnetic separation easysep mouse cd4 isolation kit ![]() Magnetic Separation Easysep Mouse Cd4 Isolation Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/stem+cell+easysep+kit+for+cd4+++t+cells/pmc05833426-176-17-22?v=STEMCELL+Technologies+Inc Average 90 stars, based on 1 article reviews
magnetic separation easysep mouse cd4 isolation kit - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Biochrom
ficoll gradient ![]() Ficoll Gradient, supplied by Biochrom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/stem+cell+easysep+kit+for+cd4+++t+cells/pm32407834-79-7-6?v=Biochrom Average 90 stars, based on 1 article reviews
ficoll gradient - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Biochrom
216 ficoll ![]() 216 Ficoll, supplied by Biochrom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/stem+cell+easysep+kit+for+cd4+++t+cells/pm32407834-79-5-6?v=Biochrom Average 90 stars, based on 1 article reviews
216 ficoll - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
STEMCELL Technologies Inc
easyplate easysep magnet ![]() Easyplate Easysep Magnet, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/stem+cell+easysep+kit+for+cd4+++t+cells/pmc08647206-123-20-23?v=STEMCELL+Technologies+Inc Average 90 stars, based on 1 article reviews
easyplate easysep magnet - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
STEMCELL Technologies Inc
rosettesep human cd4+ t cell enrichment cocktail ![]() Rosettesep Human Cd4+ T Cell Enrichment Cocktail, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/stem+cell+easysep+kit+for+cd4+++t+cells/pm32760121-272-8-15?v=STEMCELL+Technologies+Inc Average 90 stars, based on 1 article reviews
rosettesep human cd4+ t cell enrichment cocktail - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: EMBO Molecular Medicine
Article Title: Antioxidant nanozyme counteracts HIV‐1 by modulating intracellular redox potential
doi: 10.15252/emmm.202013314
Figure Lengend Snippet: A CEM‐GFP cells were pre‐treated with 50 ng/μl of Vs for 15 min and infected with 0.1 moi of CXCR4‐using HIV‐1 (NL‐4.3), and GFP fluorescence was measured at 488 nm as an indicator of HIV LTR activity. Vs treatment was repeated every 24 h for the experiment. B–D A similar assay was performed using Jurkat (CD4 + T‐cell line), and viral replication was assessed by (B) gag RT–PCR, (C) p24 ELISA in the culture supernatant, and (D) immunoblotting for p24 (viral capsid protein) in the whole cell lysate. E U937 (promonocytes) were pre‐treated with 50 ng/μl of Vs for 15 min followed by infection with 1 moi of CCR5 using HIV‐1 (NL‐AD8), and viral replication was measured by gag RT–qPCR at 24 h post‐infection (hpi). F Primary CD4 + T cells purified from human PBMCs (3 healthy donors) were activated, pre‐treated with 25 ng/μl Vs for 15 min, and infected with 0.05 moi of HIV‐1 NL‐4.3. Virus released in supernatant was quantified by p24 ELISA. Vs treatment was repeated every 48 h. Data information: All figures except (B) and (E) were analyzed by 2‐way ANOVA. (B), and (E) were analyzed by Mann–Whitney test. **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05. Data are representative of results from three independent experiments performed in triplicate (mean ± SD). Source data are available online for this figure.
Article Snippet: Briefly, 50 × 10 6 PBMCs were thawed and CD4 + T cells were isolated using
Techniques: Infection, Fluorescence, Activity Assay, Reverse Transcription Polymerase Chain Reaction, Enzyme-linked Immunosorbent Assay, Western Blot, Quantitative RT-PCR, Purification, Virus, MANN-WHITNEY
Journal: EMBO Molecular Medicine
Article Title: Antioxidant nanozyme counteracts HIV‐1 by modulating intracellular redox potential
doi: 10.15252/emmm.202013314
Figure Lengend Snippet: Human monocyte‐derived macrophages (HMDMs) were pre‐treated with 12.5 ng/µl of Vs for 15 min, followed by infection with HIV‐1 NL‐AD8. Viral release in supernatant was quantified by p24 ELISA at 7 and 14 dpi. Vs treatment was repeated every 72 h. Data are obtained from one healthy donor in duplicate (mean ± SD). Survival of HIV‐infected primary CD4 + T cells was monitored by Annexin V/PI staining at 3 dpi in presence or absence of Vs treatment. Percentage of necrotic (PI + ), early apoptotic (Annexin V + ), and late apoptotic (Annexin V + /PI + ) cells were plotted . Data are aggregated from three healthy donors (mean ± SEM). Data information: *** P < 0.001, ** P < 0.01, ns—non‐significant analyzed by 2‐way ANOVA.
Article Snippet: Briefly, 50 × 10 6 PBMCs were thawed and CD4 + T cells were isolated using
Techniques: Derivative Assay, Infection, Enzyme-linked Immunosorbent Assay, Staining
Journal: EMBO Molecular Medicine
Article Title: Antioxidant nanozyme counteracts HIV‐1 by modulating intracellular redox potential
doi: 10.15252/emmm.202013314
Figure Lengend Snippet: Schematic representation of generation of expanded CD4 + T cells and reactivation. CD4 + T cells were sorted from PBMCs of ARV‐suppressed HIV‐infected individuals and expanded in presence of PHA, IL‐2, and autologous feeder PBMCs from healthy donor. Expanded CD4 + T cells from three patients were cultured in presence of IL‐2 and ARVs, with and without 25 ng/µl Vs for 21 days. Vs treatment was given for 15 min every 3 rd day. HIV transcripts were quantified by RT–qPCR at day 14, day 21, and at 24 h post‐stimulation of cells cultured for 21 days by prostratin. Limit of detection for RT–qPCR was 3 viral transcripts per million cells. At day 21, cells were stimulated with 1 µM prostratin for 24 h and HIV transcripts were quantified by RT–qPCR. Reduction in viral stimulation in Vs‐treated samples are represented as percentage values. ND—non‐determined. Aggregate plot for 3 patients from data (C). Total HIV‐1 DNA was determined up to 21 days in cells treated with ARVs or Vs + ARVs. Data Information: (B), (D), and (E) were analyzed by one‐way ANOVA with Tukey’s multiple correction. * P < 0.05, ns—non‐significant. Data are aggregated from three ARV‐suppressed HIV‐infected human subjects (mean ± SD).
Article Snippet: Briefly, 50 × 10 6 PBMCs were thawed and CD4 + T cells were isolated using
Techniques: Infection, Cell Culture, Quantitative RT-PCR
Journal: European journal of immunology
Article Title: Toll like Receptor 2 engagement on CD4 + T cells promotes TH9 differentiation and function
doi: 10.1002/eji.201646846
Figure Lengend Snippet: Transcriptional analysis of resting CD4+ T-cells co-stimulated via CD28 or TLR2. (A) Venn diagram representing genes expressed in response to anti-CD28− and/or TLR2− co-stimulation. (B) Top genes expressed in CD4+ T cells in response to antiCD28− or TLR2 co-stimulation. (C) Relative expression of Il9 gene after CD28− and/or TLR2 co-stimulation.
Article Snippet: Briefly, peripheral blood was obtained from healthy donors, and the T cells were isolated from the buffy coat using Ficoll-Hypaque (Amersham Biosciences) density gradient centrifugation, followed by isolation with
Techniques: Expressing
Journal: European journal of immunology
Article Title: Toll like Receptor 2 engagement on CD4 + T cells promotes TH9 differentiation and function
doi: 10.1002/eji.201646846
Figure Lengend Snippet: TLR2 engagement on CD4+ T cells enhances IL9 mRNA and protein expression driven by polyclonal activation and TGF-β and IL-4. Naïve CD4+T cells from WT mice were stimulated with anti-CD3 and anti-CD28 mAbs and exogenous TGF-β (5ng/ml) and IL-4 (10ng/ml), with or without P3CSK4 (1μg/ml) for 48h. (A) Relative expression of Il9 mRNA under polarizing conditions with or without P3CSK4 (n=3).
Article Snippet: Briefly, peripheral blood was obtained from healthy donors, and the T cells were isolated from the buffy coat using Ficoll-Hypaque (Amersham Biosciences) density gradient centrifugation, followed by isolation with
Techniques: Expressing, Activation Assay
Journal: European journal of immunology
Article Title: Toll like Receptor 2 engagement on CD4 + T cells promotes TH9 differentiation and function
doi: 10.1002/eji.201646846
Figure Lengend Snippet: TLR2, but no other TLR ligands increase TGF-β and IL-4 driven IL-9 cytokine secretion. Naive CD4+ T cells were activated with anti-CD3 and anti-CD28 mAbs in the presence of different TLR ligands (1μg/ml) under non-polarizing and TH9 polarizing conditions for 48 h. IL-9 (A) and IFN-γ (B) ELISA were measured by culture supernatants. Means ± SD of three independent experiments are shown. * p < 0.05, ** p < 0.01, NS denotes non-significant.
Article Snippet: Briefly, peripheral blood was obtained from healthy donors, and the T cells were isolated from the buffy coat using Ficoll-Hypaque (Amersham Biosciences) density gradient centrifugation, followed by isolation with
Techniques: Enzyme-linked Immunosorbent Assay
Journal: European journal of immunology
Article Title: Toll like Receptor 2 engagement on CD4 + T cells promotes TH9 differentiation and function
doi: 10.1002/eji.201646846
Figure Lengend Snippet: TLR2 engagement on Antigen85B specific CD4+ T cells increases TH9 differentiation driven by TGF-β and IL-4. Naive Ag85B transgenic CD4+ T cells were co-incubated with TLR2 KO BMDM pulsed with Ag85B peptide (1μg/ml) and co-stimulated with or without TLR2 ligand (P3CSK4) under non-polarizing and TH9 polarizing conditions for 48 h. (A) CD4+ T cells were permeabilized and labeled with mAbs to IL-9 and IFN-γ and percentages of IL-9+ or IFN-γ+ cells were determined by flow cytometry. (B, C) IL-9 and IFN-γ were measured in culture supernatants by ELISA. Means ± SD of five independent experiments are shown. * p < 0.05, ** p < 0.01. NS denote non- significant.
Article Snippet: Briefly, peripheral blood was obtained from healthy donors, and the T cells were isolated from the buffy coat using Ficoll-Hypaque (Amersham Biosciences) density gradient centrifugation, followed by isolation with
Techniques: Transgenic Assay, Incubation, Labeling, Flow Cytometry, Enzyme-linked Immunosorbent Assay
Journal: European journal of immunology
Article Title: Toll like Receptor 2 engagement on CD4 + T cells promotes TH9 differentiation and function
doi: 10.1002/eji.201646846
Figure Lengend Snippet: Effect of TLR2 engagement on the expression of TH9, TH1 and TH2 transcription factors under non-polarizing or TH9− polarizing conditions. Naïve CD4+ T cells were stimulated with anti-CD3 and anti-CD28 mAbs alone (non-polarizing) or combined with TGF-β and IL-4 (TH9− polarizing) and with or without P3CSK4. Batf (A), Pu.1 (B), Tbx21 (C) and Gata3 (D) mRNA expression was determined by RT-PCR and normalized to actin.
Article Snippet: Briefly, peripheral blood was obtained from healthy donors, and the T cells were isolated from the buffy coat using Ficoll-Hypaque (Amersham Biosciences) density gradient centrifugation, followed by isolation with
Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction
Journal: European journal of immunology
Article Title: Toll like Receptor 2 engagement on CD4 + T cells promotes TH9 differentiation and function
doi: 10.1002/eji.201646846
Figure Lengend Snippet: TLR2 engagement on human CD4+ T cells enhances IL9 mRNA and protein expression driven by polyclonal activation and TGF-β and IL-4. Naïve CD4+ T cells from three human donors were stimulated with anti-CD3 (10ug/ml) and anti-CD28 mAbs (1ug/ml) and exogenous TGF-β (5ng/ml) and IL-4 (10ng/ml), with or without P3CSK4 (2μg/ml) for 48h. (A) Relative expression of Il9 mRNA under non-polarizing and polarizing conditions with or without P3CSK4 (n=3) is shown. (B) IL-9 cytokine in culture supernatants were determined by ELISA. Means ± SD of three technical replicates for each donor are shown.
Article Snippet: Briefly, peripheral blood was obtained from healthy donors, and the T cells were isolated from the buffy coat using Ficoll-Hypaque (Amersham Biosciences) density gradient centrifugation, followed by isolation with
Techniques: Expressing, Activation Assay, Enzyme-linked Immunosorbent Assay
Journal: Cell Death & Disease
Article Title: Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization
doi: 10.1038/s41419-018-0290-x
Figure Lengend Snippet: a , b Flow cytometry analysis of Th1 and Th17 cells in spleen ( a ) and DLN ( b ) from vehicle- and lenalidomide-treated WT EAE mice at day 17. Representative fluorescence activated cell sorting (FACS) plots (left) and statistics from six mice per group (right) are shown; cells are gated for CD4 + T cells. c The total numbers of MNCs in whole spinal cord and brain were isolated from vehicle- and lenalidomide-treated mice on day 17 ( n = 6). d Flow cytometry analysis of Th1 and Th17 cells in CNS-infiltrating MNCs from vehicle- and lenalidomide-treated WT EAE mice at day 17. Representative FACS plots (left) and statistics from six mice per group (right) are shown; cells are gated for CD4 + T cells. Data are presented as means ± SEM; *P < 0.05, **P < 0.01, ***P < 0.001 versus vehicle-treated controls
Article Snippet: After 4 h, splenic CD4 + T cells were isolated from MOG-treated WT mice via magnetic separation (
Techniques: Flow Cytometry, Fluorescence, FACS, Isolation
Journal: Cell Death & Disease
Article Title: Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization
doi: 10.1038/s41419-018-0290-x
Figure Lengend Snippet: a WT mice were immunized with MOG 35–55 and treated with lenalidomide (30 mg/kg, i.g.) or vehicle (0.9% CMC-Na, i.g.) combined with empty or clodronate liposome (50 mg/kg, i.v.) at indicated time points (bottom arrows represent lenalidomide or vehicle treatment, upper arrows represent liposome treatment). Mean clinical score is shown ( n = 15 per group). b , c Flow cytometry analysis of M2 and M1 macrophages in spleen ( b ) and DLN ( c ) from vehicle- and lenalidomide-treated WT EAE mice at day 17. Representative FACS plots (left) and statistics from six mice per group (right) are shown; cells are gated for F4/80 + cells. d Flow cytometry analysis of M2 macrophages in whole spinal cord and brain. CNS-infiltrating MNCs isolated from vehicle- and lenalidomide-treated WT EAE mice at day 17 stained for antibodies, including CD11b, CD206, and CD45. CD11b + CD45 hi CD206 + cells were M2 macrophages. Representative FACS plots (left) and statistics from six mice per group (right) are shown. e WT mice were immunized with MOG 35–55 on day 0 and 3 × 10 6 BMDMs treated with or without 25 nM lenalidomide for 4 h were injected intravenously into these mice on day 9, 14, and 19 ( n = 5 per group). f The mean clinical score of mice in e . g BMDMs were treated with or without 25 nM lenalidomide for 4 h. Splenic CD4 + T cells were isolated from MOG-treated WT mice, labeled with1 μM CFSE and subsequently cocultured with BMDMs at a ratio of 1:4 supplemented with MOG 35–55 peptide (20 μg/ml) for 72 h. The proliferation of CD4 + T cells was confirmed by flow cytometry analysis based on CFSE dilution. Left panel represents flowcytometric dot plot of CFSE-labeled CD4 + T cells, right panel shows the percentage of CD4 + T cells that have proliferated based on CFSE dilution ( n = 3 per group). Data are presented as means ± SEM; * P < 0.05, ** P < 0.01, *** P < 0.001
Article Snippet: After 4 h, splenic CD4 + T cells were isolated from MOG-treated WT mice via magnetic separation (
Techniques: Flow Cytometry, Isolation, Staining, Injection, Labeling